C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2009
12/17/2009	US20090312262 Peptide compound with biological activity, its preparation and its applications
12/17/2009	US20090312249 TLR4 decoy receptor protein
12/17/2009	US20090312240 Synthesis of Sialic Acid in Plants
12/17/2009	US20090311792 Fibroblast growth factor (FGF23) and methods for use
12/17/2009	US20090311751 Wood-rotting basidiomycetes for production of ligninolytic enzymes
12/17/2009	US20090311750 Methods of converting fab sequences into single chain antibody sequences
12/17/2009	US20090311749 Method for methanol independent induction from methanol inducible promoters in Pichia
12/17/2009	US20090311748 Heart20049410 polypeptides and methods of making the same
12/17/2009	US20090311747 Vectors and methods for high throughput co-expressions
12/17/2009	US20090311746 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
12/17/2009	US20090311745 Group of esterases for the enantioselective production of fine and speciality chemicals
12/17/2009	US20090311744 Expression of o-glycosylated therapeutic proteins in prokaryotic microorganisms
12/17/2009	US20090311743 Process for the Production, in Prokaryotes, of Active, Stable Transposases of Mariner Mobile Genetic Elements
12/17/2009	US20090311742 Phage-Derived Vectors and Methods for Protein Expression
12/17/2009	US20090311725 Polypeptide producing cells
12/17/2009	US20090311718 Degraded agonist antibody
12/17/2009	US20090311669 Signal for packaging of influenza virus vectors
12/17/2009	US20090311313 Methods for treating tweak-related conditions
12/17/2009	US20090311287 Novel flavivirus antigens
12/17/2009	US20090311284 Recombinant Viral Proteins And Particles
12/17/2009	US20090311282 Neutralizing gdf8 epitope-based growth enhancing vaccine
12/17/2009	US20090311281 Novel method for down-regulation of amyloid
12/17/2009	US20090311278 Novel teleost derived antimicrobial polypeptides
12/17/2009	US20090311275 Carrier for targeting nerve cells
12/17/2009	US20090311268 Cd40-binding activating antibodies
12/17/2009	US20090311263 Human vascular ibp-like growth factor
12/17/2009	US20090311262 Method for Diagnosing Cancers Expressing the HER2 Receptor or its Truncated Variants
12/17/2009	US20090311261 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
12/17/2009	US20090311260 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
12/17/2009	US20090311257 Human antibodies specific for gastrin materials and methods
12/17/2009	US20090311256 12 Human Secreted Proteins
12/17/2009	US20090311253 Dual Variable Domain Immunoglobulins and Uses Thereof
12/17/2009	US20090311248 Hepatitis C Virus Neutralizing Antibodies
12/17/2009	US20090311229 Isolation and Identification of Cross-Reactive T Cells
12/17/2009	US20090311225 Compositions of and Methods of Using Stabilized PSMA Dimers
12/17/2009	US20090311216 Recombinant interferon-beta with enhanced biological activity
12/17/2009	CA2727010A1 Methods for improving viability and productivity in cell culture
12/17/2009	CA2727006A1 Methods for obtaining high viable cell density in mammalian cell culture
12/16/2009	EP2133427A1 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
12/16/2009	EP2133419A1 Process for the preparation of dipeptides from cyanophycin employing the isolated Pseudomonas alcaligenes DIP1 CGPase CphEal
12/16/2009	EP2133416A1 Recombinant microorganism
12/16/2009	EP2133359A2 Recombinant haemophilus influenzae adhesin proteins
12/16/2009	EP2133098A1 G-CSF conjugates
12/16/2009	EP2132984A2 Interferon-like protein ZCYTO21
12/16/2009	EP2132319A1 Method for producing an antifungal peptide in a filamentous fungal host cell
12/16/2009	EP2132219A2 Ace-inhibitory peptides from whey and methods for providing the same.
12/16/2009	EP1597381B1 Production of modified glycoproteins having multiple antennary structures
12/16/2009	EP1521832B1 Anti-fragilis antibody and uses thereof
12/16/2009	EP1407023B1 Group b streptococcus antigens and corresponding dna fragments
12/16/2009	EP1384075B1 Methods of detecting early renal disease in animals
12/16/2009	EP1114189B1 Recombinant newcastle disease virus rna expression systems and vaccines
12/16/2009	CN101606066A Method for analysis of hepatitis b virus s antigen
12/16/2009	CN101605906A Human antibodies that bind cd70 and uses thereof
12/16/2009	CN101605889A Fused protein containing insulin precursor of overexpression and secretion type, DNA encoding the same and method of producing insulin
12/16/2009	CN101605887A High secretion production method of protein
12/16/2009	CN101605813A Method for increasing protein yields
12/16/2009	CN101605812A CD44 antibodies
12/16/2009	CN101605810A Chimeric human sweet-umami and umami-sweet taste receptors
12/16/2009	CN101603075A Method for measuring sortase based on yeast surface display
12/16/2009	CN101603051A Production of antibacterial peptide for treating infection by utilizing duckweed lemna minor
12/16/2009	CN101603050A Production of antibacterial peptide for treating infection by utilizing algae Chlorella vulgaris
12/16/2009	CN101603047A Establishment of prokaryotic expression and purification as well as test method of reconstruction human kidney injury molecule 1 (KIM-1)
12/16/2009	CN101603046A Establishment of prokaryotic expression and purification as well as test method of reconstruction influenza A H1N1 virus nonstructural protein NS1
12/16/2009	CN101603034A CHO cell line expressing bovine beta interferon and application thereof
12/16/2009	CN101603033A CHO cell line expressing bovine beta interferon and application thereof
12/16/2009	CN101603032A CHO cell line expressing porcine beta interferon and application thereof
12/16/2009	CN101603026A Animal origin-free low-protein culture medium suitable for animal cell product production
12/16/2009	CN101602790A Deep-sea fish skin collagen oligopeptide with function of reducing blood pressure and preparation method thereof
12/16/2009	CN101601861A Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component
12/16/2009	CN100569951C Process for producing functional soybean peptide by two-step method
12/16/2009	CN100569950C Fermentative production of D-p-hydroxyphenylglycine and D-phenylglycine
12/16/2009	CN100569800C Monoclonal antibody for resisting human myeloblast differentiation marker gene and its uses
12/16/2009	CN100569795C Oxidation resistance zymolyte rich in pollen active peptide
12/16/2009	CN100569293C Method for improving chemical stability of biological collagen to antibiotic medicine
12/15/2009	US7632980 Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems
12/15/2009	US7632935 DNA encoding a mast cell-derived membrane protein
12/15/2009	US7632931 Endogeneous nucleic acid fragment associated with an autoimmune disease, labeling method and reagent
12/15/2009	US7632925 Antibodies that bind human 17-A1/EpCAM tumor antigen
12/15/2009	US7632924 Single chain Fv fragments which bind epidermal growth factor receptors and/or HER2 genes; pharmacokinetics
12/15/2009	US7632923 Lymphotropic retrovirus disease treatment and diagnosis such as acquired immunodeficiency syndrome (AIDS); Specifically binds with high specificity and affinity a particular human APM:pathogen-derived antigen complex
12/15/2009	US7632921 Site-directed modification of FVIII
12/15/2009	US7632823 Compositions of tRNA and uses thereof
12/15/2009	US7632809 Multimeric ligands with enhanced stability
12/15/2009	US7632685 analysis an individual sample and compare with a reference biomarker profile; accurate, rapid, and sensitive method; determine an individual at risk of developing sepsis
12/15/2009	US7632677 Cell line expressing mutated human tissue-type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein
12/15/2009	US7632667 Mutan endonuclease with substrate-specific cleavage activity
12/15/2009	US7632662 Compounds, compositions and methods for producing antioxidants from carnitine
12/15/2009	US7632661 Expression elements
12/15/2009	US7632660 protein is encoded by nucleic acid molecules that interact or bind to B-aggressive lymphoma (BAL) molecules, which are differentially expressed in non-Hodgkin's lymphoma; diagnostic use; biodrug for treating B-cell lymphoma
12/15/2009	US7632659 Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
12/15/2009	US7632658 Method of using aminopeptidase to produce cleaved polypeptides
12/15/2009	US7632643 PCA3, PCA3 genes, and methods of use
12/15/2009	US7632516 Moraxella catarrhalis BASB115 polypeptides
12/15/2009	US7632515 Streptococcus pneumoniae proteins and nucleic acid molecules
12/15/2009	US7632514 a universal polypeptidic carrier for targeting molecules to a Gb3 receptor for the B-subunit of Shiga-Toxin expressing cells and its use for intracellular transport and processing of proteins, peptides, oligopeptides, glycoproteins, etc
12/15/2009	US7632511 Yeast-based therapeutic for chronic hepatitis C infection
12/15/2009	US7632504 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
12/15/2009	US7632503 Using human insulin-like growth factor-1 (IGF-1) fusion protein as therapeutic in treatment and prevention of muscular disorders
12/15/2009	US7632502 Immunoglobulin for diagnosis and prevention of yeast infections
12/15/2009	US7632499 Anti-myostatin antibodies

1 ... 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 ... 1125